Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawiger, J.
Right arrow Articles by Ballard, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawiger, J.
Right arrow Articles by Ballard, D. W.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Table of Contents  |  Next Article next article arrow

Blood, Vol. 94 No. 5 (September 1), 1999: pp. 1711-1716

Ikappa B Kinase Complex Is an Intracellular Target for Endotoxic Lipopolysaccharide in Human Monocytic Cells

By Jacek Hawiger, Ruth Ann Veach, Xue-Yan Liu, Sheila Timmons, and Dean W. Ballard

From the Department of Microbiology and Immunology and Howard Hughes Medical Institute, Vanderbilt University Medical Center, Nashville, TN.


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Endotoxic lipopolysaccharide (LPS) is a proinflammatory agonist produced by gram-negative bacteria and a contributor to the majority of the 400,000 septic shock cases recorded annually in US hospitals. The primary target cells for LPS are monocytes and macrophages. Their response consists of massive production of proinflammatory cytokines, reactive oxygen- and nitrogen-intermediates, procoagulants, and cell adhesion molecules. In turn, expression of these LPS-responsive factors contributes to collapse of the circulatory system, to disseminated intravascular coagulation, and to a 30% mortality rate. A common intracellular mechanism responsible for the expression of septic shock genes in monocytes and macrophages involves the activation of NF-kappa B. This transcription factor is regulated by a family of structurally related inhibitors including Ikappa Balpha , Ikappa Bbeta , and Ikappa Bvarepsilon , which trap NF-kappa B in the cytoplasm. In this report, the investigators show that LPS derived from different gram-negative bacteria activates cytokine-responsive Ikappa B kinases containing catalytic subunits termed IKKalpha (IKK1) and IKKbeta (IKK2). The kinetics of IKKalpha and IKKbeta activation in LPS-stimulated human monocytic cells differ from that recorded on their stimulation with tumor necrosis factor-alpha , thereby implying a distinct activation mechanism. LPS-activated IKK complexes phosphorylate all 3 inhibitors of NF-kappa B: Ikappa Balpha , Ikappa Bbeta , and Ikappa Bvarepsilon . Moreover, LPS activates IKKbeta preferentially, relative to IKKalpha . Thus, IKK complex constitutes the main intracellular target for LPS-induced NF-kappa B signaling to the nucleus in human monocytic cells to activate genes responsible for septic shock.
© 1999 by The American Society of Hematology.


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

PROINFLAMMATORY STIMULI signal to the nucleus via transcription factor NF-kappa B, which activates a set of genes responsive to inflammatory, immune, and oxidant stress. These stimuli encompass biologic agents such as endotoxic lipopolysaccharide (LPS) and bacterial superantigens (eg, toxic shock syndrome toxin and streptococcal pyrogenic exotoxin), which are responsible for the majority of septic shock cases. In addition, intracellular bacteria (eg, Mycobacterium tuberculosis), viruses (eg, human immunodeficiency virus, human T-cell lymphotropic virus, and cytomegalovirus), cytokines (tumor necrosis factor-alpha [TNF-alpha ], interlukin-1 [IL-1]), and lipid peroxides induce nuclear import of NF-kappa B.1-3 In response to these agents, the cytoplasmic ankyrin motif-rich inhibitors of NF-kappa B, Ikappa Balpha , Ikappa Bbeta , and Ikappa Bepsilon are phosphorylated, ubiquitinated, and then degraded by adenosine triphosphate (ATP)-dependent 26S proteosomes.4-9 Thus, phosphorylation-dependent proteolysis of Ikappa B proteins releases NF-kappa B for subsequent import to the nucleus. In turn, NF-kappa B stimulates transcription of a number of genes containing cognate kappa B sites in their enhancer/promoter regions. These NF-kappa B-responsive genes encode cytokines (TNF-alpha , IL-1, IL-6, IL-8, and IL-12), procoagulant molecules (tissue factor and plasminogen activator inhibitor 1), signal transducers (inducible nitric oxide synthase and cyclooxygenase 2), cell adhesion molecules (endothelial selectin, intracellular cell adhesion molecule-1, and vascular cell adhesion molecule-1), and growth factors (granulocyte-colony-stimulating factor).3,6,10 The products of these NF-kappa B-regulated genes expressed in monocytes, macrophages, and vascular endothelial cells contribute to the development of septic shock and disseminated intravascular coagulation, leading to multiple organ failure and death.1,3 These findings highlight NF-kappa B as a major intracellular mediator of the systemic inflammatory response syndrome known as sepsis and septic shock.11

The fact that multiple proinflammatory stimuli, LPS, TNF-alpha , and IL-1, involved in induction and mediation of septic shock syndrome, evoke activation of NF-kappa B indicates that the signals generated by these stimuli and their cognate receptors converge at the common step of NF-kappa B activation.6 This step appears to be specific phosphorylation of inhibitory proteins, such as Ikappa B, by their kinase(s). A primary target for Ikappa B kinases is Ikappa Balpha . This inhibitor is characterized by a signal response domain in the amino-terminal segment, ankyrin repeats in the midsection, and a PEST domain in the carboxyl terminal segment.12 The signal response domain contains two serines at positions 32 and 36, which are targeted for specific phosphorylation by Ikappa B kinases.5,13 The PEST domain bears serines phosphorylated by casein kinase II involved in constitutive turnover of Ikappa Balpha .14

The Ikappa Balpha kinase that catalyzes inducible phosphorylation of serines 32 and 36 in response to cytokines was initially reported by Chen et al15 as part of a 700-kD complex requiring ubiquitin for full activity. Subsequently, two serine/threonine kinases termed Ikappa B kinase alpha  (IKKalpha or IKK1) and Ikappa B kinase beta  (IKKbeta or IKK2) of molecular weight 85 kD and 87 kD, respectively, were identified.16-19 Both of these kinases are homologous to a previously reported conserved helix-loop-helix ubiquitous kinase with a unique structure containing a kinase domain linked to a leucine zipper domain and a helix-loop-helix domain. Both IKKalpha and IKKbeta phosphorylate serines 32 and 36 in Ikappa Balpha , suggesting functional homology as well.19

Although it is well known that primary target cells for LPS are monocytes and macrophages,3,20 the mechanism by which LPS induces NF-kappa B in this cellular setting remained unknown. Therefore, we hypothesized that the recently discovered Ikappa B kinases constitute an intracellular target for LPS. Our results provide evidence that Ikappa B kinase in human monocytic THP-1 cells is targeted by LPS, thereby assigning this multiunit kinase complex a primary role as the signal transducer responsible for NF-kappa B mobilization in response to septic-shock inducers.


    MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Reagents.   Rabbit polyclonal antibodies were generated by immunizing rabbits with synthetic peptides corresponding to amino acids 1-28 (NH2-terminal peptide) and 731-744 (COOH-terminal peptide) of human IKKalpha and a synthetic peptide corresponding to amino acids 743-756 of human IKKbeta . The peptides were covalently coupled to keyhole limpet hemocyanin before injection together with complete Freund adjuvant. The antibody lgG fraction of each antiserum was purified by absorption to and elution from Protein A Sepharose (Zymed, San Francisco, CA). Ikappa Balpha -specific (amino acids 289-317) antipeptide rabbit antibodies were prepared as described previously.9 Glutathione S-transferase (GST)-Ikappa Balpha (1-54), Ikappa Bbeta (1-44), and Ikappa Bepsilon (1-61) fusion proteins (wild type and Ikappa Balpha mutant S32A and S36A) were prepared as described.17,19,21

LPS preparations were derived from: (1) Escherichia coli 0127:B8 (extracted by Boivin method; DIFCO, Detroit, MI), (2) E coli 0127:B8 (prepared by phenol extraction and gel filtration chromatography), (3) Pseudomonas aeruginosa serotype 10 (chromatographically purified by gel filtration), and (4) Salmonella minnesota (prepared by phenol extraction and gel filtration chromatography). The latter three LPS preparations were obtained from Sigma Chemical Company (St. Louis, MO).

Cell culture.   Human monocytic THP-1 cells were cultured in RPMI 1640 medium supplemented with 10% fetal bovine serum containing no detectable LPS (<0.006 ng/mL in Limulus Amebocyte Gel Clot as determined by the manufacturer, Atlanta Biologicals, Norcross, GA), 2 mmol/L L-glutamine, and antibiotics as described.4 Where indicated, 5 mL of THP-1 cells (106/mL) were stimulated with E coli LPS O127:B8 (DIFCO) or TNF-alpha with the potency of 32,000 U per µg (Mallinckrodt, St Louis, MO) at concentrations and times specified in the text.

Immunoprecipitation and immunoblotting.   Cytoplasmic extracts were prepared from THP-1 cells by detergent lysis (0.1 % Nonidet P40 in 10 mmol/L HEPES, pH 7.9, 10 mmol/L KCl, 1.5 mmol/L MgCl2, 300 mmol/L sucrose) in the presence of phosphatase inhibitors (12.5 mmol/L beta -glycerophosphate, 2 mmol/L NaF, 100 µmol/L Na3VO4) and protease inhibitors (0.1 mmol/L EDTA, 0.1 mmol/L EGTA, 1 mg/mL pefabloc SC, 50 µg/mL antipain, 1 mg/mL aprotinin, 20 µg/mL chymostatin, 5 µg/mL E64, 1 µg/mL leupeptin, 1 µg/mL pepstatin, and 20 µg/mL phosphoramidon). Lysates were adjusted to a final concentration of 50 mmol/L HEPES (pH 7), 250 mmol/L NaCl, and 5 mmol/L EDTA before addition of specific IKKalpha or IKKbeta antibody IgG (20 µg added to reaction mixture). Specific Ikappa Balpha antipeptide antibody was used as described previously.9

Immunoprecipitations were typically performed in 400 µL reaction mixtures containing 100 to 500 µg of total cytoplasmic protein and 10 µL of protein A-Sepharose beads (Zymed). In some immunoprecipitation experiments, protein A-Sepharose beads were precoated with specific antibodies and washed once with ELB buffer (50 mmol/L HEPES, 250 mmol/L NaCl, 5 mmol/L EDTA, and 0.1% Nonidet P-40).5 Immunoprecipitates were washed three times with ELB buffer in the presence of phosphatase inhibitors, resolved by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to polyvinylidine difluoride membranes. Immunoreactive polypeptides were detected with anti-IKK antibodies and an enhanced chemiluminescence system (Amersham Pharmacia Biotech, Piscataway, NJ).

IKK assay.   Ikappa B kinase activity in immunoprecipitates obtained with anti-IKKalpha and anti-IKKbeta antibodies in cytoplasmic lysate of THP-1 cells was measured as described previously.17, 22 Briefly, cytoplasmic extracts from 5 × 106 THP-1 cells were prepared and immunoprecipitated as described above. They were immunoprecipitated with anti-IKKalpha antibody IgG (10 µg added to 100 to 500 µg of total protein), unless specified otherwise. Immunoprecipitates were washed thrice with ELB buffer and once with kinase buffer (10 mmol/L HEPES pH 7.4, 1 mmol/L MnCl2, 5 mmol/L MgCl2, 12.5 mmol/L beta -glycerophosphate, 50 µmol/L Na3VO4, 2 mmol/L NaF, 0.5 mmol/L dithiothrietol, and 10 µmol/L ATP). Immunoprecipitates were resuspended in kinase buffer (20 µL) containing 1 µg Ikappa Balpha (residues 1-54), GST fusion protein, and 5µCi of 32P-gamma -ATP (ICN cat no. 38101x, 4,500 Ci/mmol). The kinase reaction was done at 30°C for 30 minutes and was stopped by addition of Laemmli buffer containing 2.5% beta -mercaptoethanol. After a 5-minute incubation at 100°C, the mixture was spun down and the supernatant applied to SDS-PAGE (10%). Dried gels were applied to Biomax film (Eastman Kodak, Rochester, NY). In some experiments, dried gels were analyzed in Fuji FLA 2000 Fluorescent Image Analyzer (Fuji Medical Systems, Stamford, CT).

Electrophoretic mobility shift assay (EMSA).   To measure the nuclear import of NF-kappa B in THP-1 cells, EMSA was performed as described with a radiolabeled kappa B probe.4,9


    RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

Expression of endogenous IKKalpha and IKKbeta in human monocytic THP-1 cells.   At least 2 kinases specific for Ikappa Balpha and Ikappa Bbeta were recently identified in Hela and 293 EBNA cells and named IKKalpha and IKKbeta .16-19 To monitor their expression in human monocytic cells, we prepared rabbit polyclonal antibodies directed against peptides derived from the NH2-terminal segment (residues 1-28) and the COOH-terminal segment (residues 731-744) of IKKalpha and the COOH-terminal segment of IKKbeta (residues 743-756). The antibodies were monospecific for homologous peptides in an enzyme-linked immunosorbent assay using peptide-coated wells (results not shown). When cytoplasmic extracts from monocytic THP-1 cells were immunoprecipitated and then probed with these antibodies by immunoblotting, 2 bands of 85 kD and 87 kD, apparent molecular weights, were discerned with anti-IKKalpha antibody (Fig 1A, lane 1). In contrast, anti-IKKbeta antibody precipitated and reacted in immunoblotting with the 87-kD band representing IKKbeta (Fig 1B, lane 2). Thus, the anti-IKKbeta antibody was monospecific for IKKbeta and did not cross-react with IKKalpha (Fig 1B, lane 1). These bands were not visualized when antibodies were preincubated with homologous peptides before the immunoblotting (results not shown).


View larger version (75K):
[in this window]
[in a new window]
 
Fig 1. Detection of IKKalpha and IKKbeta in human monocytic THP-1 cells by immunoprecipitation and immunoblotting. Cytoplasmic lysates from unstimulated cells were immunoprecipitated with anti-IKKalpha NH2-terminal peptide antibody (lane 1) and anti-IKKbeta COOH-terminal peptide antibody (lane 2). Immunoprecipitated proteins were resolved by (A) SDS-PAGE and immunoblotted with anti-IKKalpha NH2-terminal peptide antibody, with (B) anti-IKKbeta COOH-terminal peptide antibody (NS represents nonspecific band).

Stimulus-dependent activation of IKKalpha and IKKbeta in human monocytic THP-1 cells.   Having established the presence of IKKalpha and IKKbeta in the cytoplasmic fraction of human monocytic THP-1 cells, we examined the kinase activity in immunoprecipitates obtained from LPS-stimulated cells as compared with those from TNF-alpha -stimulated cells (Fig 2A). Stimulated and nonstimulated THP-1 cells were lysed, and the cytoplasmic fraction was prepared by differential centrifugation. Immunoprecipitated IKKalpha and IKKbeta were assayed for kinase activity with 32P-gamma -ATP and a fusion protein made of Ikappa Balpha residues 1-54 attached to GST.17,22 Nonstimulated THP-1 cells had no detectable kinase activity in immunoprecipitates obtained with anti-IKKalpha antibodies (Fig 2A, lane 1). Low-level basal kinase activity was detectable in anti-IKKbeta antibody immunoprecipitates (Fig 2A, lane 4). When cells were stimulated with LPS from E coli 0127:B8 (Difco) (1 µg/mL for 30 minutes), kinase activity was readily detectable by phosphorylation of GST-Ikappa Balpha (residues 1-54) fusion protein in immunoprecipitates produced by 2 antibodies (Fig 2A, lanes 3 and 6). Phosphoimager analysis of these bands indicated that the LPS-responsive kinase activity immunoprecipitated by monospecific anti-IKKbeta antibody exceeds the activity precipitated by anti-IKKalpha antibody. Similar, albeit weaker, kinase activity of immunoprecipitated IKKalpha and IKKbeta was evoked by TNF-alpha (100 U/mL for 5 minutes) (Fig 2A, lanes 2 and 5). Kinase activity of immunoprecipitated IKKalpha and IKKbeta was specific for serines 32 and 36 of Ikappa Balpha because a fusion protein containing mutant Ikappa Balpha segment with serines 32 and 36 replaced by alanine was not phosphorylated (Fig 2B). Activation of Ikappa B kinase complex containing IKKalpha and IKKbeta by LPS in THP-1 cells was concentration dependent. At least 10 ng/mL of LPS from E coli 0127:B8 (DIFCO, Detroit, MI) was sufficient to induce detectable IKKalpha and IKKbeta activity (Fig 3). By comparison, the lowest concentration of TNF-alpha inducing similar activation was 30 U/mL or approximately 1 ng/mL. All preparations of LPS tested induced activation of IKKalpha and IKKbeta . These included LPS derived from E coli 0127:B8, P aeruginosa, and S minnesota (Fig 4). The activation of IKKalpha and IKKbeta by structurally diverse LPS from different gram-negative bacterial species indicates that IKK complex responds to all endotoxic LPS tested. However, the method of extraction of LPS derived from the same E coli 0127:B8 serotype results in different IKK complex activating potency of LPS (Fig 4, lanes 2 and 3).


View larger version (30K):
[in this window]
[in a new window]
 
Fig 2. Stimulus-dependent activation of IKKalpha and IKKbeta in human monocytic THP-1 cells. (A) Nonstimulated cells (lanes 1, 4), TNF-alpha -stimulated (100 U/mL)(5 minutes) cells (lanes 2, 5), and LPS E coli 0127:B8 (1 µg/mL)-stimulated (30 minutes) cells (lanes 3, 6). Lanes 1-3 represent immunoprecipitates obtained with anti-IKKalpha antibody; and lanes 4-6 represent immunoprecipitates obtained with anti IKKbeta antibody. The IKK kinase assay was done as described in Materials and Methods by using Ikappa Balpha -GST fusion protein as the substrate. (B) IKKalpha and IKKbeta activity toward wild type Ikappa Balpha substrate and Ikappa Balpha mutant (S32A and S36A) substrate prepared as GST fusion proteins. The cells were stimulated with TNF-alpha (100 U/mL) for 5 minutes and with LPS (1 µg/mL) for 30 minutes.



View larger version (28K):
[in this window]
[in a new window]
 
Fig 3. Concentration-dependent activation of IKKalpha and IKKbeta by LPS and TNF-alpha . Human monocytic THP-1 cells were stimulated with increasing concentrations of LPS for 30 minutes or TNF-alpha for 5 minutes and cytoplasmic lysates were prepared with anti-IKKalpha antibody. The IKK kinase assay was done as described in Materials and Methods; the substrate was a fusion protein made of wild-type Ikappa Balpha (amino acids 1-54) and GST.



View larger version (28K):
[in this window]
[in a new window]
 
Fig 4. Activation of IKKalpha and IKKbeta in human monocytic THP-1 cells by LPS derived from different gram-negative bacteria. Lane 1, Unstimulated cells; Lane 2, LPS from E coli 0127:B8 extracted by Boivin method (DIFCO); Lane 3, LPS from E coli 0127:B8 prepared by phenol extraction and gel filtration chromatography (Sigma); Lane 4, LPS from P aeruginosa serotype 10. LPS from S minnesota. Human monocytic THP-1 cells were stimulated with different preparations of LPS at 1 µg/mL for 30 minutes and the IKK kinase assay was done as specified in Materials and Methods.The kinase complex was immunoprecipitated with anti-IKKbeta antibody.

IKKalpha and IKKbeta are differentially activated by LPS and TNF-alpha .   Stimulation of human monocytic THP-1 cells by LPS or TNF-alpha was followed by determination of enzymatic activity of IKKalpha and IKKbeta in cytoplasmic extracts of stimulated cells prepared at different time intervals. Three NF-kappa B inhibitors, Ikappa Balpha , Ikappa Bbeta , and Ikappa Bepsilon , presented as GST fusion proteins were tested as phosphorylation substrates in standard in vitro kinase assays with immune complex containing IKK. LPS stimulation of THP-1 cells for 10 minutes was sufficient to induce measurable kinase activity, which peaked at 30 minutes (Fig 5). The significant increase in Ikappa Balpha kinase activity at 10 minutes is consistent with phosphorylation and degradation of Ikappa Balpha in LPS-treated THP-1 cells after 10 minutes stimulation as documented by immunoblotting with specific Ikappa Balpha antipeptide antibody. Concurrently, the nuclear import of NF-kappa B monitored by the electrophoretic mobility shift assay shows progressive increase reaching maximum at 30 minutes (Fig 6A and B). Significantly, all three inhibitory proteins, Ikappa Balpha , Ikappa Bbeta , and Ikappa Bepsilon , used as GST fusion proteins at equivalent concentrations were phosphorylated with similar kinetics in response to LPS. In contrast, TNF-alpha stimulation of THP-1 cells resulted in much faster kinetics of phosphorylation of Ikappa Balpha -GST fusion protein reaching peak at 3 to 5 minutes and declining after 20 minutes (Fig 5). This pattern of rapid activation by TNF-alpha is consistent with much faster degradation of endogenous Ikappa Balpha and nuclear import of NF-kappa B reaching maximum at 10 minutes in TNF-alpha -stimulated THP1 cells (Fig 6A and B). The 5 times lower concentration of TNF-alpha (20 U/mL) did not change the rapid course of IKKalpha /IKKbeta activation (results not shown). Thus, the differences in activation kinetics of Ikappa B kinase complex induced by LPS and TNF-alpha suggest that these proinflammatory agonists evoke different signaling pathways resulting in activation of IKKalpha -containing and IKKbeta -containing complex in human monocytic cells.


View larger version (51K):
[in this window]
[in a new window]
 
Fig 5. Time course of LPS-induced activation of IKKalpha and IKKbeta as compared with that induced by TNF-alpha . (A) LPS-induced phosphorylation of 1µg Ikappa Balpha -GST, Ikappa Bbeta -GST, and Ikappa Bvarepsilon -GST fusion proteins; (B) TNF-alpha -induced phosphorylation of Ikappa Balpha -GST fusion protein. The IKK kinase assay was done as specified in Materials and Methods and the kinase complex was immunoprecipitated with anti-IKKalpha antibody.



View larger version (41K):
[in this window]
[in a new window]
 
Fig 6. Time course of LPS-induced degradation of Ikappa Balpha and nuclear import of NF-kappa B. (A) Immunoblotting of Ikappa Balpha in nonstimulated (time 0) and TNF-alpha -stimulated or LPS-stimulated THP-1 cells. (B) Electrophoretic mobility shift assay of NF-kappa B in nuclear fractions isolated from nonstimulated (time 0) and TNF-alpha -stimulated or LPS-stimulated THP-1 cells. LPS from E coli 0127:B8 was used in concentration of 1 µg/mL and TNF-alpha at 100 U/mL.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

The results presented here have several important implications for the cellular and molecular pathogenesis of septic shock induced by LPS. First, our studies provide evidence that Ikappa B kinase complex containing IKKalpha and IKKbeta is an intracellular target for LPS produced by different gram-negative bacteria (enterobacteriaceae and nonenterobacteriaceae).

Second, IKKbeta appears to be a more LPS-responsive signal transducer than IKKalpha based on observed kinase activity (Fig 2). This is consistent with recent demonstration that IKKalpha is not required for signaling induced by proinflammatory cytokines, IL-1, or TNF-alpha .23-25 The lowest concentration of LPS that induces detectable activation of IKKalpha and IKKbeta in human monocytic THP-1 cells was 10 ng/mL. Treatment of human peripheral blood mononuclear cells ("adherent monocytes") with 100 ng/mL of E coli 0111:B4 lipopolysaccharide also induces IKK activity, thus validating THP-1 cells as a model for studying LPS-induced IKK activation in human cells of the myelomonocytic lineage.26 Moreover, LPS-stimulated and TNF-alpha -stimulated IKK complex can phosphorylate not only inhibitory proteins Ikappa Balpha and Ikappa Bbeta , but also Ikappa Bepsilon . The Ikappa B kinases provide a pivotal checkpoint in NF-kappa B-mediated signaling to the nucleus. Thus, activation of Ikappa B kinases by LPS in human monocytic cells constitutes an important link in understanding the NF-kappa B recruitment in molecular pathogenesis of septic shock. Whether continuing activation of Ikappa B kinases in vivo by LPS derived from different gram-negative bacteria results in persistent nuclear import of NF-kappa B demonstrated in nonsurvivors of septic shock11 remains to be established with in vivo models. Importantly, kinetics of phosphorylation of all three inhibitory proteins, Ikappa Balpha , Ikappa Bbeta , and Ikappa Bepsilon , as demonstrated herein by IKK complex activated by LPS can contribute to progressive activation of the nuclear import of NF-kappa B.

Third, the distinct activation kinetics of IKKalpha -containing and IKKbeta -containing complex by LPS and TNF-alpha in human monocytic cells is consistent with different rate of the nuclear import of NF-kappa B in these cells (Fig 6).4,9,27 These agonists signal through distinct receptors (toll-like receptor 2 and 4 v TNF-alpha receptor 1 and 2).28-31 Receptor-proximal steps in intracellular signaling induced by TNF-alpha that interacts with its cognate receptor, TNFR1, and by LPS interacting with its cognate receptor TLR2 differ.29 Whereas TNF-alpha -induced signaling requires TRAF2 in mammalian cell transfectants, LPS-induced signaling via TLR2 seems to require TRAF6.29,32 The latter is required for IL-1 induced signaling, which also uses an adaptor protein MyD88.33-35 Dominant-negative mutants of MyD88 and TRAF6 expressed in TLR2- and IL-1R-transfected cells selectively blocked signaling evoked by LPS and IL-1 but remained ineffective toward TNF-alpha -induced signaling.29,32 These differences in receptor-proximal signaling may explain the different kinetics of IKK complex activation by LPS and TNF-alpha in human monocytic THP-1 cells used in our experiments. Further dissection of LPS-stimulated and TNF-alpha -stimulated specific pathways of IKK complex activation will help in the development of new inhibitors designed to interrupt potentially lethal lipopolysaccharide-induced intracellular mechanism of septic shock.


    ACKNOWLEDGMENT

The authors thank Traci Tidwell, Susan Rowlinson, and Erica Holleran for assistance in preparation of the manuscript, Zhi-Liang Chu and Min Dai for preparation of GST fusion proteins, and Hiroyasu Nakano, Juntendo University School of Medicine, Tokyo, Japan, for plasmid pGEX-4T-Ikappa Bepsilon (1-61).


    FOOTNOTES

Submitted December 31, 1998; accepted May 5, 1999.

Supported in part by the National Institutes of Health, Grant Nos. R37HL30647, HL45994, and AI33839.

The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. section 1734 solely to indicate this fact.

Address reprint requests to Jacek Hawiger, MD, PhD, Department of Microbiology & Immunology, Vanderbilt University School of Medicine, A-5321 MCN, 1161 21st Ave South, Nashville, TN 37232-2363; e-mail: jacek.hawiger{at}mcmail.vanderbilt.edu.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

1. Bone RC: The pathogenesis of sepsis. Ann Intern Med 115:457, 1991

2. Wenzel RP, Pinsky MR, Ulevitch RJ, Young L: Current understanding of sepsis. Clin Infect Dis 22:407, 1996[Medline] [Order article via Infotrieve]

3. Hawiger J: Lipopolysaccharide-induced signal transduction and gene transcription, in Brigham KL (ed): Endotoxin and the Lungs, vol 77. New York, NY, Marcel Dekker, 1994, p 69.

4. Cordle SR, Donald R, Read MA, Hawiger J: Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells. J Biol Chem 268:11803, 1993[Abstract/Free Full Text]

5. Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW: Coupling of a signal response domain in Ikappa Balpha to multiple pathways for NF-kappa B activation. Mol Cell Biol 15:2809, 1995[Abstract]

6. Ghosh S, May MJ, Kopp EB: NF-kappa B and rel proteins: Evolutionarily conserved mediators of immune responses. Annu Rev Immun 16:225, 1998[Medline] [Order article via Infotrieve]

7. Whiteside ST, Epinat JC, Rice NR, Israel A: I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. EMBO J 16:1413, 1997[Medline] [Order article via Infotrieve]

8. Scherer DC, Brockman JA, Chen Z, Maniatis T, Ballard DW: Signal-induced degradation of Ikappa Balpha requires site-specific ubiquitination. Proc Natl Acad Sci USA 92:11259, 1995[Abstract/Free Full Text]

9. Donald R, Ballard DW, Hawiger J: Proteolytic processing of NF-kappa B/I kappa B in human monocytes. ATP-dependent induction by pro-inflammatory mediators. J Biol Chem 270:9, 1995[Abstract/Free Full Text]

10. Mackman N: Regulation of the tissue factor gene. FASEB J 9:883, 1995[Abstract]

11. Bohrer H, Qui F, Zimmerman T, Zhang Y, Jllmer T, Mannel D, Bottiger BW, Stern DM, Waldherr R, Saeger H-D, Ziegler R, Bierhaus A, Martin E, Nawroth PP: Role of NF-kappa B in the mortality of sepsis. J Clin Invest 100:972, 1997[Medline] [Order article via Infotrieve]

12. Baldwin AS: The NF-kappa B and I-kappa B proteins: New discoveries and insights. Annu Rev Immunol 14:649, 1996[Medline] [Order article via Infotrieve]

13. Brown K, Gerstberger S, Carlson L, Franzoso G, Siebenlist U: Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 267:1485, 1995[Abstract/Free Full Text]

14. Barroga CF, Stevenson JK, Schwartz EM, Verma I: Constitutive phosphorylation of Ikappa Balpha by casein kinase II. Proc Natl Acad Sci USA 92:7637, 1995[Abstract/Free Full Text]

15. Chen ZJ, Parent L, Maniatis T: Site-specific phosphorylation of Ikappa Balpha by a novel ubiquitination-dependent protein kinase activity. Cell 84:853, 1996[Medline] [Order article via Infotrieve]

16. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M: Identification and characterization of an Ikappa B kinase. Cell 90:373, 1997[Medline] [Order article via Infotrieve]

17. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M: A cytokine-responsive Ikappa B kinase that activates the transcription factor NF-kappa B. Nature 388:548, 1997[Medline] [Order article via Infotrieve]

18. Zandi E, Rothwarf DM, Delhase M, Hayakawa M, Karin M: The Ikappa B kinase complex (IKK) contains two kinase subunits, IKKalpha and IKKbeta , necessary for Ikappa B phosphorylation and NF-kappa B activation. Cell 91:243, 1997[Medline] [Order article via Infotrieve]

19. Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li JW, Young DB, Barbosa M, Mann M: IKK-1 and IKK-2: Cytokine-activated Ikappa B kinases essential for NF-kappa B activation. Science 278:860, 1997[Abstract/Free Full Text]

20. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431, 1990[Abstract/Free Full Text]

21. Nakano H, Shindo M, Sakon S, Nishinaka S, Mihara M, Yagita H, Okumura K: Differential regualtion of Ikappa B kinase alpha  and beta  by two upstream kinases, NF-kappa B-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc Natl Acad Sci USA 95:3537, 1998[Abstract/Free Full Text]

22. Chu Z-L, DiDonato JA, Hawiger J, Ballard DW: The tax oncoprotein of human T-cell leukemia virus type 1 associates with and persistently activates Ikappa B kinases containing IKKalpha and IKKbeta . J Biol Chem 273:15891, 1998[Abstract/Free Full Text]

23. Hu Y, Baud V, Delhase M, Zhang P, Deerinck T, Ellisman M, Johnson R, Karin M: Abnormal morphogenesis but intact IKK activation in mice lacking the IKK subunit of Ikappa B kinase. Science 284:316, 1999[Abstract/Free Full Text]

24. Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi O, Kawai T, Sanjo H, Yoshikawa K, Terada N, Akira N: Limb and skin abnormalities in mice lacking IKK. Science 284:313, 1999[Abstract/Free Full Text]

25. Delhase M, Hayakawa M, Chen Y, Karin M: Positive and negative regulation of Ikappa B kinase activity through IKKbeta subunit phosphorylation. Science 284:309, 1999[Abstract/Free Full Text]

26. O'Connell MA, Bennett BL, Mercurio F, Manning AM, Mackman N: Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J Biol Chem 273:30410, 1998[Abstract/Free Full Text]

27. Hohmann HP, Roland R, Scheidereit C, Van Loon APGM: Maintenance of NF-kappa B activity is dependent on protein synthesis and the continuous presence of external stimuli. Mol Cell Biol 11:259, 1991[Abstract/Free Full Text]

28. Yang R-B, Mark MR, Gray A, Huang A, Xie MH, Zhang M, Goddard A, Wood WI, Gurney AL, Godowski PJ: Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling. Nature 395:284, 1998[Medline] [Order article via Infotrieve]

29. Kirschning CJ, Wesche H, Ayres TM: Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide. J Exp Med 188:2091, 1998[Abstract/Free Full Text]

30. Poltorak A, Xialong H, Smirnova I, Liu M, Huggel C, Du X, Birdwell D, Alejos E, Silva M, Galanos C, Freudenberg M, Ricciardi-Castagnoli P, Layton B, Beutler B: Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 gene. Science 282:2085, 1998[Abstract/Free Full Text]

31. Liu Z, Hsu H, Goeddel DV, Karin M: Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-kappa B activation prevents cell death. Cell 87:565, 1996[Medline] [Order article via Infotrieve]

32. Zhang F, Kirschning C, Mancinelli R, Xu X, Jin Y, Faure E, Mantovani A, Rothe M, Muzio M, Arditi M: Bacterial lipopolysaccharide activates nuclear factor-B through interleukin-1 signaling mediators in cultured human dermal endothelial cells and mononuclear phagocytes. J Biol Chem 274:7611, 1999[Abstract/Free Full Text]

33. Wesche H, Henzel W, Shillinglaw W, Li S, Cao Z: MyD88: An adapter that recruits IRAK to the IL-1 receptor complex 7. Immunity 7:837, 1997[Medline] [Order article via Infotrieve]

34. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, Ghosh S, Janeway C: MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol Cell 2:253, 1998[Medline] [Order article via Infotrieve]

35. Burns K, Martinon F, Esslinger C, Pahl H, Schneider P, Bodmer J, Marco F, French L, Tschopp J: MyD88, an adapter protein involved in interleukin-1 signaling. J Biol Chem 273:12203, 1998[Abstract/Free Full Text]


© 1999 by The American Society of Hematology.
 

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
B. Janic, T. M. Umstead, D. S. Phelps, and J. Floros
Modulatory effects of ozone on THP-1 cells in response to SP-A stimulation
Am J Physiol Lung Cell Mol Physiol, February 1, 2005; 288(2): L317 - L325.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Syrovets, B. Buchele, C. Krauss, Y. Laumonnier, and T. Simmet
Acetyl-Boswellic Acids Inhibit Lipopolysaccharide-Mediated TNF-{alpha} Induction in Monocytes by Direct Interaction with I{kappa}B Kinases
J. Immunol., January 1, 2005; 174(1): 498 - 506.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Xiong, H. Li, Y. Chen, J. Zhao, and J. C. Unkeless
Interaction of TRAF6 with MAST205 Regulates NF-{kappa}B Activation and MAST205 Stability
J. Biol. Chem., October 15, 2004; 279(42): 43675 - 43683.
[Abstract] [Full Text] [PDF]


Home page
Annals of Clinical & Laboratory ScienceHome page
J. Sun, F. Li, J. Chen, and J. Xu
Effect of Ketamine on NF-kappa B Activity and TNF-alpha Production in Endotoxin-Treated Rats
Ann. Clin. Lab. Sci., April 1, 2004; 34(2): 181 - 186.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
P. A. Henriksen, M. Hitt, Z. Xing, J. Wang, C. Haslett, R. A. Riemersma, D. J. Webb, Y. V. Kotelevtsev, and J.-M. Sallenave
Adenoviral Gene Delivery of Elafin and Secretory Leukocyte Protease Inhibitor Attenuates NF-{kappa}B-Dependent Inflammatory Responses of Human Endothelial Cells and Macrophages to Atherogenic Stimuli
J. Immunol., April 1, 2004; 172(7): 4535 - 4544.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Takada and B. B. Aggarwal
Genetic Deletion of the Tumor Necrosis Factor Receptor p60 or p80 Sensitizes Macrophages to Lipopolysaccharide-induced Nuclear Factor-{kappa}B, Mitogen-activated Protein Kinases, and Apoptosis
J. Biol. Chem., June 20, 2003; 278(26): 23390 - 23397.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
S. C. Pingle, J. F. Sanchez, D. M. Hallam, A. L. Williamson, S. B. Maggirwar, and V. Ramkumar
Hypertonicity Inhibits Lipopolysaccharide-Induced Nitric Oxide Synthase Expression in Smooth Muscle Cells by Inhibiting Nuclear Factor {kappa}B
Mol. Pharmacol., June 1, 2003; 63(6): 1238 - 1247.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. S. Carter, K. N. Pennington, B. J. Ungurait, and D. W. Ballard
In Vivo Identification of Inducible Phosphoacceptors in the IKK{gamma}/NEMO Subunit of Human I{kappa}B Kinase
J. Biol. Chem., May 23, 2003; 278(22): 19642 - 19648.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
S. Kiriakidis, E. Andreakos, C. Monaco, B. Foxwell, M. Feldmann, and E. Paleolog
VEGF expression in human macrophages is NF-{kappa}B-dependent: studies using adenoviruses expressing the endogenous NF-{kappa}B inhibitor I{kappa}B{alpha} and a kinase-defective form of the I{kappa}B kinase 2
J. Cell Sci., February 15, 2003; 116(4): 665 - 674.
[Abstract] [Full Text] [PDF]


Home page
Eur Respir JHome page
M.M. Monick and G.W. Hunninghake
Activation of second messenger pathways in alveolar macrophages by endotoxin
Eur. Respir. J., July 1, 2002; 20(1): 210 - 222.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
N. Silverman and T. Maniatis
NF-{kappa}B signaling pathways in mammalian and insect innate immunity
Genes & Dev., September 15, 2001; 15(18): 2321 - 2342.
[Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
D. C. Saha, R. S. Barua, M. E. Astiz, E. C. Rackow, and L-J. Eales-Reynolds
Monophosphoryl lipid A stimulated up-regulation of reactive oxygen intermediates in human monocytes in vitro
J. Leukoc. Biol., September 1, 2001; 70(3): 381 - 385.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
T. Syrovets, M. Jendrach, A. Rohwedder, A. Schule, and T. Simmet
Plasmin-induced expression of cytokines and tissue factor in human monocytes involves AP-1 and IKK{beta}-mediated NF-{kappa}B activation
Blood, June 15, 2001; 97(12): 3941 - 3950.
[Abstract] [Full Text] [PDF]


Home page
Innate ImmunityHome page
C. Alexander and E. Th. Rietschel
Invited review: Bacterial lipopolysaccharides and innate immunity
Innate Immunity, June 1, 2001; 7(3): 167 - 202.
[Abstract] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
N. H. Purcell, C. Yu, D. He, J. Xiang, N. Paran, J. A. DiDonato, S. Yamaoka, Y. Shaul, and A. Lin
Activation of NF-{kappa}B by hepatitis B virus X protein through an I{kappa}B kinase-independent mechanism
Am J Physiol Gastrointest Liver Physiol, April 1, 2001; 280(4): G669 - G677.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Ruckdeschel, O. Mannel, K. Richter, C. A. Jacobi, K. Trulzsch, B. Rouot, and J. Heesemann
Yersinia Outer Protein P of Yersinia enterocolitica Simultaneously Blocks the Nuclear Factor-{{kappa}}B Pathway and Exploits Lipopolysaccharide Signaling to Trigger Apoptosis in Macrophages
J. Immunol., February 1, 2001; 166(3): 1823 - 1831.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hawiger, J.
Right arrow Articles by Ballard, D. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hawiger, J.
Right arrow Articles by Ballard, D. W.
Related Collections
Right arrow Immunobiology
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 1999 by American Society of Hematology         Online ISSN: 1528-0020